Pharmaceutical composition comprising levocarnitine and dobesilate
AssigneesTianjin Nankai Share Pharmaceutical Science & Technology Co., Ltd., Xizang Linzhi Parkson Pharmaceutical Co., Ltd., Nankai Share Pharmaceutical Co., Ltd., Liaoning Sebest Pharmaceuticl Co., Ltd.
InventorsYong Wang, Xin Zhao, Mo Chen, Ning Tian
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising levocarnitine and dobesilate is provided. Also provided are a method for regulating the level of serum creatinine and/or blood urea nitrogen and a method for treating and/or preventing the diseases influencing renal function, for example, including but not limiting to various primary, secondary nephritis, renal lesions, renal insufficiency, nephritic syndrome, even renal failure, uremia, as well as the complications induced by the diseases and/or disorders influencing renal function for example, such as cardiovascular diseases, diabetes and the like.
Claims13
A pharmaceutical composition comprising levocarnitine and dobesilate.
A use of levocarnitine and dobesilate in the preparation of a medicament for regulating the level of serum creatinine and/or blood urea nitrogen.
A use of levocarnitine and dobesilate in the preparation of a medicament for treating and/or preventing diseases and/or disorders influencing renal function, for example, including but not limited to various primary and secondary nephritis, renal lesions, renal insufficiency, nephritic syndrome, and even renal failure and uremia, as well as complications induced by the diseases and/or disorders influencing renal function, for example cardiovascular diseases, diabetes and the like.
Dependencies are inferred from the claim text.